2025-2034 Xerostomia Therapeutics Market Roadmap: Insights for Competitive Advantage

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Xerostomia Therapeutics Market Size By 2025?
The market size for xerostomia therapeutics has seen robust growth in recent times. The market is forecasted to surge from $2.14 billion in 2024 to $2.26 billion in 2025, with a compound annual growth rate (CAGR) of 5.7%. This growth during the historic period is due to factors like a rise in xerostomia cases among the elderly population, advancements in research and development of more effective xerostomia products, increasing awareness regarding products related to xerostomia, a rise in medical conditions, and an increasing rate of chronic diseases.

How Big Is the Xerostomia Therapeutics Market Size Expected to Grow by 2029?
In the coming years, the market for xerostomia therapeutics is poised for strong expansion, with its value projected to reach $2.79 billion in 2029, representing a compound annual growth rate (CAGR) of 5.3%. Factors contributing to this growth over the forecasted period include the wide availability of affordable medications, elevated incidences of oral health disorders, increased awareness among healthcare professionals, government-led initiatives, and the upturn in medication use. Noteworthy trends for this forecast period encompass the use of artificial saliva and saliva replacements, advancements in technology and innovative products, personalized and targeted treatments, telehealth paired with remote monitoring, and the surge in non-invasive therapies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/xerostomia-therapeutics-global-market-report

Which Key Market Drivers Powering Xerostomia Therapeutics Market Expansion and Growth?
The surging incorporation of chemotherapy in cancer therapies is set to drive the expansion of the xerostomia therapeutics market. Chemotherapy in cancer care involves the use of potent drugs aimed at eliminating or restricting the proliferation of cancer cells. The growing recognition of chemotherapy in cancer care is largely attributed to its success in selectively locating and annihilating cancerous cells in the body. Xerostomia therapeutics consists of medications that stimulate saliva production or mouthwash that boosts taste discernment, simplifying eating and ensuring proper nourishment for patients. For instance, in January 2022, data from the National Cancer Institute, a US-based governmental entity, estimated that the US has 18.1 million cancer survivors, which constitute 5.4% of the total population. By 2032, worldwide cancer survivors will number 22.5 million, a 24.4% rise from the current projection. Hence, the escalating use of chemotherapy in cancer therapy is fuelling the development of the xerostomia therapeutics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15700&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Xerostomia Therapeutics Market?
Leading businesses in the xerostomia therapeutic field are innovating non-invasive, patient-friendly solutions such as oral sprays to cater to the growing need for convenient and efficient methods of managing dry mouth. Oral sprays enable accurate application to mouth areas affected by dryness, providing moisture and lubrication exactly where it's needed. For example, in July 2023, K Pharmaceuticals, a pharmaceutical firm from India, introduced Aquoral, an oral spray that's clinically proven to offer relief from xerostomia, also referred to as dry mouth. This condition can result from a range of factors including medications and diseases, causing discomfort, difficulties in eating and swallowing, and potential oral health issues. Aquoral offers lasting relief for up to six hours, forming a durable protective layer over the mouth, minimizing moisture loss and boosting comfort levels. Unlike traditional water-based treatments that need constant reapplication, Aquoral contains patented Oxidized Glycerol Triesters (OGT), a plant-sourced lipid-based technology that provides superior protection.

What Are the Emerging Segments in the Xerostomia Therapeutics Market?
The xerostomia therapeutics market covered in this report is segmented -

1) By Type: Artificial Saliva Or Saliva Substitutes, Salivary Stimulants
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies, Hypermarkets And Supermarkets
3) By End-User: Adult, Pediatric

Subsegments:
1) By Artificial Saliva Or Saliva Substitutes: Oral Sprays, Gels, Lozenges, Mouthwashes
2) By Salivary Stimulants: Prescription Drugs, Over-The-Counter (Otc) Products, Chewing Gums And Lozenges

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15700&type=smp

Who Are the Global Leaders in the Xerostomia Therapeutics Market?
Major companies operating in the xerostomia therapeutics market are Bayer AG, 3M Company, GlaxoSmithKline plc, Colgate-Palmolive Company, Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Church & Dwight* Co. Inc., Cipla Ltd., Hikma Pharmaceuticals PLC, Lupin Limited, Synedgen Inc., Sunstar Suisse S.A., Advanz Pharma Corp., Pharmascience Inc., Mission Pharmacal Company, Dentaid Ltd., Cyclacel Pharmaceuticals Inc., Parnell Pharmaceuticals Holdings Ltd., Teva Pharmaceutical Industries Ltd., Forward Science Holding Inc., ICPA Health Products Ltd., CCMed Ltd., Bio Cosmetics Laboratories S.L., Quest Products LLC, Acacia Pharma, Saliwell Limited, OraCoat, Oralieve UK Ltd., OraPharma Inc., OraVital Inc

Which are the Top Profitable Regional Markets for the Xerostomia Therapeutics Industry?
North America was the largest region in the xerostomia therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the xerostomia therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15700

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.